<DOC>
	<DOCNO>NCT00565526</DOCNO>
	<brief_summary>Background : Sj ( SqrRoot ) ( Delta ) gren Syndrome ( SS ) autoimmune disease affect glands produce saliva tear , cause dry eye dry mouth . Researchers know exact cause SS , believe may cause abnormality autonomic nervous system ( ANS ) stimulate gland . Objectives : To good understand ANS function patient SS . To compare information ANS function healthy individual patient SS . Eligibility : Patients Sj ( SqrRoot ) ( Delta ) gren Syndrome 18 year age old , pregnant breastfeeding . Participants ask taper discontinue use certain medication dietary supplement ANS test . Participants must willing discontinue use alcohol tobacco 24 hour prior test . Design : The study require one inpatient admission and/or outpatient visit NIH Clinical Center . The following test procedure perform : - Saliva , tear , sweat production measurement evaluate function gland . - Testing change cardiovascular system , include blood pressure blood flow testing , electrocardiogram design evaluate hemodynamic change control ANS . - Testing change gastrointestinal system , include swallow assessment study , barium swallow study , gastric empty study design evaluate gastrointestinal function control ANS . - Tests evaluate ANS function response certain drug ( edrophonium , glucagon acetylcholine ) . - Self-reported questionnaire ANS function emotional/psychological well-being . Additional procedure test may include follow : - Blood sample . - Optional skin biopsy study sweat gland nerve supply skin .</brief_summary>
	<brief_title>Evaluation Role Autonomic Nervous System Sj ( SqrRoot ) ( Delta ) Gren Syndrome</brief_title>
	<detailed_description>Sj ( SqrRoot ) ( Delta ) gren syndrome ( SjS ) systemic exocrinopathy affect high 5 percent population . It manifest predominantly dry eye , dry mouth , fatigue . The exocrinopathy encounter alone ( primary SjS ) approximately one half patient presence another autoimmune disorder rheumatoid arthritis , systemic lupus erythematosus , systemic sclerosis ( secondary SjS ) . The widely accept classification SjS American-European consensus classification criterion SjS . ( Vitali , Bombardieri et al . 2002 ) Current understanding pathogenesis SjS stem assumption autoimmune destruction exocrine glands lead hypofunction symptom dryness . The exist evidence however fully support assumption explain underlying pathogenic mechanism SjS follow reason : 1 ) Discordance severely affect function abundance histologically normal ex vivo functional salivary gland ; 2 ) least 20 % patient evidence systemic autoimmunity ; 3 ) Animal model SjS develop glandular dysfunction long develop autoimmunity ; 4 ) Dryness relate symptom respond poorly immunosuppressive , include new biologics , fairly well secretagogues pilocarpine . 5 ) No pathogenic antibody target epitope identify date unify pathogenesis syndrome . All exocrine gland innervated autonomic nervous system ( ANS ) dysautonomia mimic phenotype SjS , particularly cardinal manifestation , xerostomia xerophthalmia . Thus hypothesize ANS dysfunction central pathogenesis SjS propose systematically study ANS function cohort patient primary SjS compare normative data age sex-matched control . This protocol call comprehensive evaluation autonomic function , use physiological , neuropharmacologic , neurochemical , image approach , identify consistent distinctive pattern ANS involvement SjS thereby improve diagnosis understand pathophysiologic mechanism SjS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<mesh_term>Primary Dysautonomias</mesh_term>
	<mesh_term>Autonomic Nervous System Diseases</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Diagnosis primary Sjogren syndrome base AmericanEuropean Consensus Group Sjogren syndrome classification criterion healthy volunteer . 2 . Both gender minority . 3 . Age entry least 18 less 65 year . EXCLUSION CRITERIA : 1 . Current use medication know significantly influence activity sympathetic parasympathetic nervous system hold safely time ANS test 2 . Known coexist diagnosis ANS dysfunction ( healthy volunteer ) 3 . Medicationsrequiring diabetes mellitus 4 . Diabetic autonomic neuropathy 5 . Vitamin B12 , folate deficiency , require replacement 6 . Hepatic failure ( AST ALT great 1.5 x upper limit normal ) 7 . Renal failure ( GFR le 30 ml/min , estimate MDRD ) 8 . Congestive heart failure ( Class IIIV ) 9 . Refractory ventricular arrhythmias 10 . Symptomatic coronary heart disease 11 . Previously establish diagnosis sinus node dysfunction 12 . Severe anemia ( Hgb less 8 ) 13 . Psychosis 14 . Pregnant lactate woman 15 . A candidate subject exclude , judgment Principal Investigator , protocol participation would place subject substantially increase acute medical risk . 16 . Not able provide inform consent Medications : A candidate subject exclude clinical consideration require subject continue treatment drug likely interfere scientific result i.e . tricyclic antidepressant fludrocortisone . Subjects know suspected allergy hypersensitivity test drug exclude receive drug . Subjects must take medication daily follow category exclude : tricyclic antidepressant , beta blocker , barbiturate , safely hold test . Subjects unable discontinue nicotine alcohol temporarily exclude . Subjects discontinue medication subject subject physician discuss Principal Investigator , Dr. Nikolov , Associate Investigator , Dr. Goldstein . If decided discontinuing medication would unsafe , subject exclude study . Subjects must discontinue use alcohol tobacco throughout period test protocol . Herbal Medicines Dietary Supplements : Certain herbal medicine dietary supplement know suspect interfere experimental result , herbal medicine dietary supplement must discontinue enrollment study . For many herbal medicine dietary supplement , mechanism action therefore possible effect experimental result unknown . In case subject wish continue herbal medicine dietary supplement study , search available medical literature fail identify effect know expect interfere experimental result , subject may participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 10, 2014</verification_date>
	<keyword>Autonomic Nervous System</keyword>
	<keyword>Sjogren 's Syndrome</keyword>
	<keyword>Pathogenesis</keyword>
	<keyword>Cholinergic</keyword>
	<keyword>Parasympathetic</keyword>
	<keyword>Sjogren Syndrome</keyword>
</DOC>